Literature DB >> 16751397

Protein kinase C (PKC) alpha and PKC theta are the major PKC isotypes involved in TCR down-regulation.

Marina von Essen1, Martin W Nielsen, Charlotte M Bonefeld, Lasse Boding, Jeppe M Larsen, Michael Leitges, Gottfried Baier, Niels Odum, Carsten Geisler.   

Abstract

It is well known that protein kinase C (PKC) plays an important role in regulation of TCR cell surface expression levels. However, eight different PKC isotypes are present in T cells, and to date the particular isotype(s) involved in TCR down-regulation remains to be identified. The aim of this study was to identify the PKC isotype(s) involved in TCR down-regulation and to elucidate the mechanism by which they induce TCR down-regulation. To accomplish this, we studied TCR down-regulation in the human T cell line Jurkat, in primary human T cells, or in the mouse T cell line DO11.10 in which we either overexpressed constitutive active or dominant-negative forms of various PKC isotypes. In addition, we studied TCR down-regulation in PKC knockout mice and by using small interfering RNA-mediated knockdown of specific PKC isotypes. We found that PKCalpha and PKCtheta were the only PKC isotypes able to induce significant TCR down-regulation. Both isotypes mediated TCR down-regulation via the TCR recycling pathway that strictly depends on Ser(126) and the di-leucine-based receptor-sorting motif of the CD3gamma chain. Finally, we found that PKCtheta was mainly implicated in down-regulation of directly engaged TCR, whereas PKCalpha was involved in down-regulation of nonengaged TCR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751397     DOI: 10.4049/jimmunol.176.12.7502

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  PKC alpha regulates Sendai virus-mediated interferon induction through HDAC6 and β-catenin.

Authors:  Jianzhong Zhu; Carolyn B Coyne; Saumendra N Sarkar
Journal:  EMBO J       Date:  2011-09-27       Impact factor: 11.598

2.  DAP12 impacts trafficking and surface stability of killer immunoglobulin-like receptors on natural killer cells.

Authors:  Tiernan J Mulrooney; Phillip E Posch; Carolyn Katovich Hurley
Journal:  J Leukoc Biol       Date:  2013-05-28       Impact factor: 4.962

3.  The SCHOOL of nature: I. Transmembrane signaling.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-01

Review 4.  The yin and yang of protein kinase C-theta (PKCθ): a novel drug target for selective immunosuppression.

Authors:  Elizabeth Yan Zhang; Kok-Fai Kong; Amnon Altman
Journal:  Adv Pharmacol       Date:  2013

5.  β-Arrestin-1 mediates the TCR-triggered re-routing of distal receptors to the immunological synapse by a PKC-mediated mechanism.

Authors:  Elena Fernández-Arenas; Enrique Calleja; Nadia Martínez-Martín; Severine I Gharbi; Rosana Navajas; Noel García-Medel; Petronila Penela; Antonio Alcamí; Federico Mayor; Juan P Albar; Balbino Alarcón
Journal:  EMBO J       Date:  2014-02-06       Impact factor: 11.598

6.  Pharmacologic inhibition of PKCα and PKCθ prevents GVHD while preserving GVL activity in mice.

Authors:  Kelley M K Haarberg; Jun Li; Jessica Heinrichs; Dapeng Wang; Chen Liu; Crystina C Bronk; Kane Kaosaard; Alexander M Owyang; Sacha Holland; Esteban Masuda; Kin Tso; Bruce R Blazar; Claudio Anasetti; Amer A Beg; Xue-Zhong Yu
Journal:  Blood       Date:  2013-08-01       Impact factor: 22.113

7.  PKCalpha regulates platelet granule secretion and thrombus formation in mice.

Authors:  Olga Konopatskaya; Karen Gilio; Matthew T Harper; Yan Zhao; Judith M E M Cosemans; Zubair A Karim; Sidney W Whiteheart; Jeffery D Molkentin; Paul Verkade; Steve P Watson; Johan W M Heemskerk; Alastair W Poole
Journal:  J Clin Invest       Date:  2009-01-19       Impact factor: 14.808

8.  Pertussis toxin signals through the TCR to initiate cross-desensitization of the chemokine receptor CXCR4.

Authors:  Olivia D Schneider; Alison A Weiss; William E Miller
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

9.  Phospholipase D in TCR-Mediated Signaling and T Cell Activation.

Authors:  Minghua Zhu; Daniel P Foreman; Sarah A O'Brien; Yuefei Jin; Weiguo Zhang
Journal:  J Immunol       Date:  2018-01-31       Impact factor: 5.422

Review 10.  Protein kinase Calpha: disease regulator and therapeutic target.

Authors:  Olga Konopatskaya; Alastair W Poole
Journal:  Trends Pharmacol Sci       Date:  2009-12-05       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.